Hormone replacement therapy and breast cancer: Estimate of risk

Nathan J. Coombs, Richard Taylor, Nicholas Wilcken, John Boyages*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

12 Citations (Scopus)

Abstract

Information about risk of breast cancer with hormone replacement therapy is conflicting Data that can be used to derive individual risk are presented to help decision making Cumulative absolute risk of breast cancer (to 79 years) falls with increasing age in women who do not take hormone replacement therapy Use of hormone replacement therapy increases a woman's cumulative risk only slightly The effect on the general incidence of breast cancer incidence would be greater.

Original languageEnglish
Pages (from-to)347-349
Number of pages3
JournalBritish Medical Journal
Volume331
Issue number7512
Publication statusPublished - 6 Aug 2005
Externally publishedYes

Fingerprint

Dive into the research topics of 'Hormone replacement therapy and breast cancer: Estimate of risk'. Together they form a unique fingerprint.

Cite this